Immunic (IMUX) Change in Account Payables (2013 - 2026)

Immunic (IMUX) has 14 years of Change in Account Payables data on file, last reported at $1.1 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Account Payables rose 152.38% year-over-year to $1.1 million; the trailing twelve-month figure through Mar 2026 stood at $4.4 million (up 702.6% YoY), and the FY2025 full-year result was $1.2 million, down 60.67% from the prior year.
• Change in Account Payables eased to $1.1 million in Q1 2026, from $2.2 million in the prior quarter.
• In the past five years, Change in Account Payables ranged from a high of $2.3 million in Q4 2024 to a low of -$2.1 million in Q3 2024.
• A 5-year average of $417000.0 and a median of $986000.0 in 2023 frame the typical range for Change in Account Payables.
• Peak annual rise in Change in Account Payables reached 602.27% in 2023, while the deepest fall reached 530.77% in 2023.
• Tracing IMUX's Change in Account Payables over 5 years: stood at -$352000.0 in 2022, then soared by 602.27% to $1.8 million in 2023, then advanced by 28.62% to $2.3 million in 2024, then fell by 4.84% to $2.2 million in 2025, then plunged by 49.58% to $1.1 million in 2026.
• Business Quant data shows IMUX's Change in Account Payables at $1.1 million in Q1 2026, $2.2 million in Q4 2025, and -$31000.0 in Q3 2025.